Crystal structure of a bifunctional transformylase and cyclohydrolase enzyme in purine biosynthesis

[1]  G. P. Beardsley,et al.  Human 5-Aminoimidazole-4-carboxamide Ribonucleotide Transformylase/Inosine 5′-Monophosphate Cyclohydrolase , 2001, The Journal of Biological Chemistry.

[2]  S. Benkovic,et al.  Human AICAR transformylase: role of the 4-carboxamide of AICAR in binding and catalysis. , 2000, Biochemistry.

[3]  I. Wilson,et al.  Crystallization and preliminary crystallographic investigations of avian 5-aminoimidazole-4-carboxamide ribonucleotide transformylase-inosine monophosphate cyclohydrolase expressed in Escherichia coli. , 2000, Acta crystallographica. Section D, Biological crystallography.

[4]  D. Appling,et al.  Characterization of Two 5-Aminoimidazole-4-carboxamide Ribonucleotide Transformylase/Inosine Monophosphate Cyclohydrolase Isozymes from Saccharomyces cerevisiae * , 2000, The Journal of Biological Chemistry.

[5]  T. Yeates,et al.  The structure of adenylosuccinate lyase, an enzyme with dual activity in the de novo purine biosynthetic pathway. , 2000, Structure.

[6]  S E Ealick,et al.  Crystal structure of Escherichia coli PurE, an unusual mutase in the purine biosynthetic pathway. , 1999, Structure.

[7]  R. Stroud,et al.  The structural mechanism for half-the-sites reactivity in an enzyme, thymidylate synthase, involves a relay of changes between subunits. , 1999, Biochemistry.

[8]  J. Stubbe,et al.  X-ray crystal structure of aminoimidazole ribonucleotide synthetase (PurM), from the Escherichia coli purine biosynthetic pathway at 2.5 A resolution. , 1999, Structure.

[9]  S. Benkovic,et al.  A multisubstrate adduct inhibitor of AICAR transformylase. , 1999, Journal of medicinal chemistry.

[10]  S. B. Gates,et al.  Enzyme inhibition, polyglutamation, and the effect of LY231514 (MTA) on purine biosynthesis. , 1999, Seminars in oncology.

[11]  D. Harrison,et al.  The crystal structure of methylglyoxal synthase from Escherichia coli. , 1999, Structure.

[12]  A. Jabs,et al.  Non-proline cis peptide bonds in proteins. , 1999, Journal of molecular biology.

[13]  J. Stubbe,et al.  X-ray crystal structure of glycinamide ribonucleotide synthetase from Escherichia coli. , 1998, Biochemistry.

[14]  R J Read,et al.  Crystallography & NMR system: A new software suite for macromolecular structure determination. , 1998, Acta crystallographica. Section D, Biological crystallography.

[15]  A. Jabs,et al.  Peptide bonds revisited , 1998, Nature Structural &Molecular Biology.

[16]  K. Wilson,et al.  The structure of SAICAR synthase: an enzyme in the de novo pathway of purine nucleotide biosynthesis. , 1998, Structure.

[17]  K. Anderson,et al.  Structure and functional relationships in human pur H. , 1998, Advances in experimental medicine and biology.

[18]  J. L. Smith,et al.  Coupled formation of an amidotransferase interdomain ammonia channel and a phosphoribosyltransferase active site. , 1997, Biochemistry.

[19]  Z. Otwinowski,et al.  [20] Processing of X-ray diffraction data collected in oscillation mode. , 1997, Methods in enzymology.

[20]  E A Merritt,et al.  Raster3D: photorealistic molecular graphics. , 1997, Methods in enzymology.

[21]  G. Bricogne,et al.  [27] Maximum-likelihood heavy-atom parameter refinement for multiple isomorphous replacement and multiwavelength anomalous diffraction methods. , 1997, Methods in enzymology.

[22]  T. Terwilliger,et al.  Correlated phasing of multiple isomorphous replacement data. , 1996, Acta crystallographica. Section D, Biological crystallography.

[23]  B. Cronstein,et al.  The anti-inflammatory mechanism of sulfasalazine is related to adenosine release at inflamed sites. , 1996, Journal of immunology.

[24]  G. P. Beardsley,et al.  The Human purH Gene Product, 5-Aminoimidazole-4-carboxamide Ribonucleotide Formyltransferase/IMP Cyclohydrolase , 1996, The Journal of Biological Chemistry.

[25]  S. Jones,et al.  Principles of protein-protein interactions. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[26]  J. Abrahams,et al.  Methods used in the structure determination of bovine mitochondrial F1 ATPase. , 1996, Acta crystallographica. Section D, Biological crystallography.

[27]  C. Sessa,et al.  Mechanism of cytotoxicity of 5,10-dideazatetrahydrofolic acid in human ovarian carcinoma cells in vitro and modulation of the drug activity by folic or folinic acid. , 1994, British Journal of Cancer.

[28]  M. Lawrence,et al.  Shape complementarity at protein/protein interfaces. , 1993, Journal of molecular biology.

[29]  B. Cronstein,et al.  The antiinflammatory mechanism of methotrexate. Increased adenosine release at inflamed sites diminishes leukocyte accumulation in an in vivo model of inflammation. , 1993, The Journal of clinical investigation.

[30]  C. Sander,et al.  Protein structure comparison by alignment of distance matrices. , 1993, Journal of molecular biology.

[31]  V S Lamzin,et al.  Automated refinement of protein models. , 1993, Acta crystallographica. Section D, Biological crystallography.

[32]  I. Wilson,et al.  Crystal structure of glycinamide ribonucleotide transformylase from Escherichia coli at 3.0 A resolution. A target enzyme for chemotherapy. , 1992, Journal of molecular biology.

[33]  S. Morgan,et al.  Inhibition of folate-dependent enzymes by non-steroidal anti-inflammatory drugs. , 1992, The Biochemical journal.

[34]  G. Schulz.  Binding of nucleotides by proteins , 1992, Current Biology.

[35]  A. Brunger.  Free R value: a novel statistical quantity for assessing the accuracy of crystal structures. , 1992 .

[36]  J. Dixon,et al.  De novo purine nucleotide biosynthesis: cloning, sequencing and expression of a chicken PurH cDNA encoding 5-aminoimidazole-4-carboxamide-ribonucleotide transformylase-IMP cyclohydrolase. , 1991, Gene.

[37]  P. Kraulis.  A program to produce both detailed and schematic plots of protein structures , 1991 .

[38]  J. Zou,et al.  Improved methods for building protein models in electron density maps and the location of errors in these models. , 1991, Acta crystallographica. Section A, Foundations of crystallography.

[39]  R. Moran,et al.  A new folate antimetabolite, 5,10-dideaza-5,6,7,8-tetrahydrofolate is a potent inhibitor of de novo purine synthesis. , 1989, The Journal of biological chemistry.

[40]  C. Allegra,et al.  Inhibition of phosphoribosylaminoimidazolecarboxamide transformylase by methotrexate and dihydrofolic acid polyglutamates. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[41]  M. L. Connolly.  Solvent-accessible surfaces of proteins and nucleic acids. , 1983, Science.

[42]  S. Benkovic,et al.  On the purification and mechanism of action of 5-aminoimidazole-4-carboxamide-ribonucleotide transformylase from chicken liver. , 1981, Biochemistry.

[43]  B. Matthews.  Solvent content of protein crystals. , 1968, Journal of molecular biology.